Valuation (10%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 121.26 | N/A |
PEG Ratio (TTM) | 13.20 | N/A |
P/S Ratio (TTM) | N/A | N/A |
P/B Ratio (TTM) | -8.05 | N/A |
P/FCF Ratio (TTM) | -46.93 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (5%) |
Company | Industry |
---|---|---|
ROA (TTM) | 0.21% | N/A |
ROE (TTM) | -13.43% | N/A |
Net Profit Margin (TTM) | N/A | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 2,059.57% | N/A | N/A |
Revenue | N/A | N/A | N/A |
Net Income | 651.35% | N/A | N/A |
Cash Flow | -14.72% | N/A | N/A |
Health (30%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 26.42 | N/A |
Quick Ratio (TTM) | 26.42 | N/A |
D/E Ratio (TTM) | N/A | N/A |
Interest Coverage (TTM) | 0.69 | N/A |
Piotroski F-Score | N/A | N/A |
Altman Z-Score | 1.10 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |